| NEWS
by: Motley Rice
Chambers USA released its annual rankings and has listed both Motley Rice’s securities fraud and product liability practices as nationally ranked – their highest ranking.
| NEWS
by: Motley Rice
Glyphosate bans have been enacted in several U.S. cities and foreign countries due to health concerns.
| NEWS
by: Motley Rice
Motley Rice welcomes Joshua M. Neuman as senior counsel and Josey M. Richards and Alexandra A. Stulpin joined as associates at Three Logan Square in Philadelphia.
| NEWS
by: Motley Rice
Sarah Wynn-Williams—Meta whistleblower and author of the recently released book “Careless People”—testified before the U.S. Senate April 9 about many of the company’s negative business practices.
| NEWS
by: Motley Rice
Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation alleging pay-for-delay tactics with popular narcolepsy drug Xyrem®.
| BLOG
by: Grace P. Chandler
One study found that people with diabetes who take semaglutide are over four times more likely to be diagnosed with NAION than people with diabetes who had not been prescribed a GLP-1 RA drug like Ozempic®.
| BLOG
by: M. Nolan Webb
In the United States alone, as the result of their employment, 2.6 million workers suffer nonfatal injuries or illnesses each year. Another 5,000 workers in the United States die at work annually. Aware of staggering statistics like these, the AFL-CIO declared April 28 Workers’ Memorial Day in 1989.
| NEWS
by: Motley Rice
Our client lost their livelihood after being diagnosed with nonarteritic anterior ischemic optic neuropathy (NAION). Despite stopping Ozempic, they remain legally blind.
| NEWS
by: Motley Rice
A tourist helicopter lost control and plunged into the Hudson River on April 10, 2025, claiming the lives of a family of five and the pilot.
| BLOG
by: Nathan D. Finch
In 2024, the EPA took the long overdue action of banning chrysotile asbestos—the only form of asbestos currently known to be used or imported in the U.S.